All free · no sign up

CJC-1295 + Ipamorelin Dosage Calculator

Calculate dosages for the popular CJC-1295 + Ipamorelin combination. Pre-filled for a 5mg blend vial with 2ml BAC water.

Dose Reference Table

Pre-calculated for a 5mg vial + 2ml BAC water = 2,500 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.

Dose Inject Volume (ml) Syringe Units
100mcg 0.040 ml 4 units
200mcg 0.080 ml 8 units
300mcg 0.120 ml 12 units
500mcg 0.200 ml 20 units
1000mcg 0.400 ml 40 units

About CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin is one of the most popular peptide combinations in growth hormone research. CJC-1295 is a GHRH (growth hormone-releasing hormone) analogue that stimulates the pituitary gland to release GH, while Ipamorelin is a selective GHRP (growth hormone-releasing peptide) that amplifies GH release through a complementary mechanism.

When combined, these two peptides act synergistically — CJC-1295 provides the GHRH signal while Ipamorelin amplifies the response, resulting in a greater GH pulse than either peptide alone. This combination is popular in research for studying GH secretion, body composition, recovery, and sleep quality.

The blend is commonly available as a pre-mixed vial (most often in a 1:1 ratio by mass) or as two separate vials administered together. For a 5mg blend vial with 2ml BAC water, concentration is 2500 mcg/ml. A typical dose of 300mcg CJC-1295 + 200mcg Ipamorelin in a blend would require calculating based on the actual blend ratio.

This combination is typically administered 1–3 times daily, with the final dose before sleep to align with the body's natural nighttime GH pulsatility.

Frequently Asked Questions

Common research doses are 100–300mcg of each peptide per injection, 1–3 times daily. The final dose of the day is often timed before sleep to align with natural GH pulsatility.
CJC-1295 with DAC (Drug Affinity Complex) binds to albumin, extending its half-life to 6–8 days, allowing weekly dosing. CJC-1295 without DAC (also called Mod GRF 1-29) has a shorter half-life of 30 minutes, requiring more frequent dosing.
Research suggests GH release is blunted by elevated blood glucose. For this reason, many researchers administer these peptides in a fasted state (2+ hours after eating) to potentially maximize GH release.
Research protocols typically run 3–6 months, with some researchers cycling on and off. Effects on body composition and recovery are generally observed over weeks to months of consistent use.
Yes — when using separate vials, CJC-1295 and Ipamorelin can be drawn into the same syringe for a single injection. This is a common practice in research protocols. Blend vials pre-combine both peptides.
CJC-1295 Dosage Standalone CJC-1295 calculator. Ipamorelin Dosage Standalone Ipamorelin calculator. Sermorelin Dosage GHRH analogue calculator. Hexarelin Dosage GHRP calculator.